FIELD: organic chemistry, medicine, biochemistry, pharmacy.
SUBSTANCE: invention relates to phthalimido-derivatives of the general formula (I): 
wherein X means -N= or -CH=; R1 means -CO-NR5R6, -CHR7-(CH2)n-CO-NR5R6, -(CH2)n-NR5R6, -(CH2)n-COOR8, -(CH2)n-CN, -CHR7-(CH2)n-CF3, -(CH2)n-NH-COR9, -(CH2)n-NH-COOR8, -(CH2)n-piperidinyl, -(CH2)n-morpholinyl, -(CH2)n-tetrahydrofuranyl, -(CH2)n-thiophenyl or -(CH2)n-isoxazolyl wherein a heterocyclic ring can be substituted with (C1-C6)-alkyl; -(CH2)n-phenyl wherein phenyl ring can be substituted with halogen atom or halogen-(C1-C6)-alkyl; -(CH2)p-OR8, -(CH2)p-SR8, -(CH2)p-SO-R9 or -(CH2)n-CS-NR5R6; R2 means hydrogen atom (H), (C1-C6)-alkyl, -(CH2)p-OR10, -(CH2)p-SR or benzyl; R3 means H, (C1-C6)-alkyl; R4 means halogen atom, halogen-(C1-C6)-alkyl, cyano-, (C1-C6)-alkoxy- or halogen-(C1-C6)-alkoxy-group; Each R5 and R6 means independently of one another H, (C1-C6)-alkyl; R7 means H, -OH, (C1-C6)-alkoxy-group; R8 means H, (C1-C6)-alkyl; R9 means (C1-C6)-alkyl; R10 means H, (C1-C6)-alkyl; m = 1, 2 or 3; n = 0, 1 or 2; p = 1 or 2, and their pharmaceutically acceptable salts. Compounds of the formula (I) inhibit activity of monoamine oxidase B (MAO B) that allows their using as a drug.
EFFECT: valuable medicinal and biochemical properties of compounds.
14 cl, 4 sch, 1 tbl, 53 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2,3-DIHYDROISOINDOL-1-ONES POSSESSING INHIBITORY EFFECT ON MAO B ACTIVITY | 2003 |
|
RU2322437C2 |
| NEW DERIVATIVES OF HYDROXAMIC ACID USEFUL FOR TREATMENT OF PATIENTS WITH DISEASES ASSOCIATED WITH DEGENERATION OF CONNECTIVE TISSUE | 1997 |
|
RU2168497C2 |
| INHIBITORS OF TWO SITES OF BINDING ACETYLCHOLINESTERASE FOR TREATMENT OF THE ALZHEIMER'S DISEASE | 2003 |
|
RU2325379C2 |
| CONDENSED HETEROCYCLIC SUCCINAMIDE COMPOUNDS | 2001 |
|
RU2298554C2 |
| DERIVATIVES OF FLUOROBENZAMIDE AND MEDICINAL AGENT BASED ON THEREOF | 2003 |
|
RU2314289C2 |
| ARYLETHINYL DERIVATIVES | 2011 |
|
RU2573560C2 |
| ORTHO-SUBSTITUTED PENTAFLUOROSULPHANYLBENZOLES, METHOD OF OBTAINING SAID COMPOUNDS, AS WELL AS USE OF SAID COMPOUNDS AS VALUABLE SYNTHESIS INTERMEDIATES | 2004 |
|
RU2372332C2 |
| 4, O-SUBSTITUTED ISOINDOLINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND METHODS FOR USING THEM | 2008 |
|
RU2471794C2 |
| ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2567753C2 |
| HYDROXYBENZAMIDE DERIVATIVES AND USE THEREOF AS Hsp90 INHIBITORS | 2006 |
|
RU2458919C2 |
